A 22-Year Chronicle: The Rise of China’s Innovative Drugs
Apr 23,2026
In an industry, capital, talent, information and opportunities often first emerge where people gather.
Apr 22,2026
JunHe Law Firm and TONACEA are jointly hosting this special session, bringing together a number of JunHe experts in hot-topic legal areas within the pharmaceutical industry to share insights and engage in in-depth discussions on key issues.
CPIC 2026 | TONACEA and NAPPA Officially Sign Strategic Cooperation Agreement
Apr 22,2026
TONACEA, a renowned industrial ecosystem platform in China's biomedical innovation sector, has officially reached a strategic cooperation agreement with the North American Pharmaceutical Professionals Alliance (NAPPA).
CPIC 2026 | Call for Applications! Young Elite Fellowship Program Officially Launched
Apr 22,2026
This is the most anticipated premier event in China's biopharmaceutical field in 2026, and also a historic moment for young professionals in China's pharmaceutical industry.
Apr 22,2026
This year's conference features a series of special roundtable sessions focused on in-depth discussions of core industry issues. Among them, the debate on "Chinese Biotech: Integrated R&D, Manufacturing & Commercialization vs. Specialized Division of Labor" has been passionately curated by Tao Qiucheng of Yatai Capital!
CPIC 2026 | China-Japan Health Industry Collaboration Forum
Apr 21,2026
China-Japan Pharmaceutical Cooperation Is Entering a New Phase
CPIC 2026 | Four Organizations Become Guiding Institutions of the Conference
Apr 21,2026
Authoritative Endorsement! The Conference Receives Comprehensive Guidance and Support from Shanghai's Core Biomedical Institutions.